Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working PartyGerrit Jan Schuurhuis, Gert J. Ossenkoppele, Michael Heuser et al.|Blood|2018Cited by 1k
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working PartyMichael Heuser, Jacqueline Cloos, Sylvie Freeman et al.|Blood|2021Cited by 714
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic LeukemiaRaphaël Itzykson, Éric Solary, Olivier Kosmider et al.|Journal of Clinical Oncology|2013Cited by 543
Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantationTetsuichi Yoshizato, Seishi Ogawa, Yasuhito Nannya et al.|Blood|2017Cited by 352
MOLECULAR BIOLOGY OF THE CELLA. Victor Hoffbrand, Keith Gomez, Paresh Vyas et al.|Unknown|2018Cited by 262